BioSpace News Archive

Provides ADVANZ PHARMA with an immediate and direct commercial presence in Germany , France , Spain , Italy , and the Benelux region, while strengthening its existing presence in the Nordics and the United Kingdom Further diversifies ADVANZ PHARMA’s portfolio of medicines by adding established and innovative high-quality brands that are sold in more than 60 countries around

Marinus Pharmaceuticals, Inc. today provided a business update on its clinical development activities and reported its financial results for the year ended December 31, 2019.

The Delta Companies (TDC), a leading healthcare staffing firm for providers nationwide, has announced the acquisition of Dallas-based Foreman Therapy Services (FTS), a therapy-focused staffing company specializing in home health

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, is pleased to confirm that a hard copy of the Annual Report and Accounts for the year ended December 31, 2019, the Notice of Annual General Meeting and a Form of Proxy have been mailed to Shareholders of record as of March 13, 2020.

Healthix and NYCIG, two of New York’s leading public health information exchanges (HIEs), today announced they are a merged organization.

Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and standards-based research technology solutions announces an average turnaround time of fewer than five days, from initial submission to full IRB approval for coronavirus disease (COVID-19) protocol reviews to date.

Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced Steven F. Murray as CEO effective March 16, 2020, succeeding the current Chairman & CEO John J. Viscogliosi, who is stepping down effective immediately to focus his efforts on further expanding Viscogliosi Brothers,

CureVac AG announced today that Ingmar Hoerr, CEO of the company, will take a temporary leave of absence for medical reasons. Ingmar Hoerr’s leave is not caused by coronavirus

Immunic, Inc. announced financial results for the year ended December 31, 2019 and highlighted recent achievements.

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced its financial results for the year ended December 31, 2019.